Literature DB >> 19307646

Effect of nitazoxanide on cryptosporidiosis in experimentally infected neonatal dairy calves.

T L Ollivett1, D V Nydam, D D Bowman, J A Zambriski, M L Bellosa, T C Linden, T J Divers.   

Abstract

Cryptosporidium is a zoonotic protozoan that is most often diagnosed in association with diarrhea in 1- to 3-wk-old dairy calves. There are neither consistently effective nor approved antimicrobial drugs for treatment in animals. The objective of this study was to test nitazoxanide (NTZ) as a treatment for cryptosporidiosis in experimentally infected dairy calves. A randomized, controlled, and blinded trial was performed using Holstein bull calves obtained from a large commercial dairy. All births were attended by study personnel and calves were fed 4 L of heat-treated colostrum within 1 h of birth. Calves were randomly assigned to treatment or placebo group and maintained for a 32-feeding (16 d) study period. Twenty-three calves were enrolled with 3 lost to follow up. Thirteen calves were assigned to the treatment group and 7 calves to the placebo group. All calves were inoculated with 1 x 10(6) viable Cryptosporidium parvum oocysts at feeding 3. Treatment was a commercially available NTZ product and the placebo was the carrier of the same product. Nitazoxanide was administered at 1.5 g twice per day for 5 d. Nitazoxanide or placebo treatment began after feeding 10 and when the fecal score was greater than 1 out of 3. Outcome measurements included twice-daily fecal and health scores and a once-daily oocyst count by an immunofluorescent antibody assay. Data were analyzed by nonparametric and time-to-event methods. Measures of passive transfer of antibodies, initial body weight, and onset of oocyst shedding were not different between treatment and control calves. Eighty-five percent of the NTZ-treated calves stopped shedding oocysts by the end of the observation period whereas only 15% of the placebo group stopped shedding. The median number of feedings with a fecal score equal to 3 was 2 in the NTZ group while it was 6 in the placebo group. Calves receiving NTZ were 0.13 times as likely to have severe and sustained diarrhea than control calves (95% confidence interval, 0.02-0.98). Treating calves with NTZ reduced the duration of oocyst shedding and improved fecal consistency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19307646     DOI: 10.3168/jds.2008-1474

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  13 in total

1.  Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis.

Authors:  Deborah A Schaefer; Dana P Betzer; Kylie D Smith; Zachary G Millman; Hannah C Michalski; Sarah E Menchaca; Jennifer A Zambriski; Kayode K Ojo; Matthew A Hulverson; Samuel L M Arnold; Kasey L Rivas; Rama S R Vidadala; Wenlin Huang; Lynn K Barrett; Dustin J Maly; Erkang Fan; Wesley C Van Voorhis; Michael W Riggs
Journal:  J Infect Dis       Date:  2016-10-17       Impact factor: 5.226

2.  Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.

Authors:  Rama Subba Rao Vidadala; Kasey L Rivas; Kayode K Ojo; Matthew A Hulverson; Jennifer A Zambriski; Igor Bruzual; Tracey L Schultz; Wenlin Huang; Zhongsheng Zhang; Suzanne Scheele; Amy E DeRocher; Ryan Choi; Lynn K Barrett; Latha Kallur Siddaramaiah; Wim G J Hol; Erkang Fan; Ethan A Merritt; Marilyn Parsons; Gail Freiberg; Kennan Marsh; Dale J Kempf; Vern B Carruthers; Nina Isoherranen; J Stone Doggett; Wesley C Van Voorhis; Dustin J Maly
Journal:  J Med Chem       Date:  2016-07-01       Impact factor: 7.446

3.  The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum.

Authors:  Mona Gaber; Lamia Ahmed A Galal; Haiam Mohamed Mahmoud Farrag; Dalia M Badary; Samia S Alkhalil; Nahed Elossily
Journal:  Infect Drug Resist       Date:  2022-01-20       Impact factor: 4.177

Review 4.  Bovine cryptosporidiosis: impact, host-parasite interaction and control strategies.

Authors:  Sarah Thomson; Carly A Hamilton; Jayne C Hope; Frank Katzer; Neil A Mabbott; Liam J Morrison; Elisabeth A Innes
Journal:  Vet Res       Date:  2017-08-11       Impact factor: 3.683

Review 5.  Cryptosporidiosis: A zoonotic disease concern.

Authors:  Natapol Pumipuntu; Supawadee Piratae
Journal:  Vet World       Date:  2018-05-23

6.  Specific increase of Fusobacterium in the faecal microbiota of neonatal calves infected with Cryptosporidium parvum.

Authors:  Madoka Ichikawa-Seki; Daisuke Motooka; Aiko Kinami; Fumi Murakoshi; Yoko Takahashi; Junya Aita; Kei Hayashi; Atsushi Tashibu; Shota Nakamura; Tetsuya Iida; Toshihiro Horii; Yoshifumi Nishikawa
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

7.  Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis.

Authors:  Christopher S Lunde; Erin E Stebbins; Rajiv S Jumani; Md Mahmudul Hasan; Peter Miller; John Barlow; Yvonne R Freund; Pamela Berry; Rianna Stefanakis; Jiri Gut; Philip J Rosenthal; Melissa S Love; Case W McNamara; Eric Easom; Jacob J Plattner; Robert T Jacobs; Christopher D Huston
Journal:  Nat Commun       Date:  2019-06-27       Impact factor: 14.919

8.  A Proposed Target Product Profile and Developmental Cascade for New Cryptosporidiosis Treatments.

Authors:  Christopher D Huston; Thomas Spangenberg; Jeremy Burrows; Paul Willis; Timothy N C Wells; Wesley van Voorhis
Journal:  PLoS Negl Trop Dis       Date:  2015-10-08

9.  The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.

Authors:  Sangun Lee; Melanie Harwood; Don Girouard; Marvin J Meyers; Mary A Campbell; Gillian Beamer; Saul Tzipori
Journal:  PLoS One       Date:  2017-10-03       Impact factor: 3.240

10.  Impact of confinement housing on study end-points in the calf model of cryptosporidiosis.

Authors:  Geneva Graef; Natalie J Hurst; Lance Kidder; Tracy L Sy; Laura B Goodman; Whitney D Preston; Samuel L M Arnold; Jennifer A Zambriski
Journal:  PLoS Negl Trop Dis       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.